Circumventing glucocorticoid-mediated hyperinsulinemia via the activation of PPARalpha

Cell Cycle. 2009 Aug;8(15):2311-2. doi: 10.4161/cc.8.15.9220. Epub 2009 Aug 15.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fenofibrate / therapeutic use*
  • Gene Expression
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / antagonists & inhibitors
  • Humans
  • Hyperinsulinism / chemically induced
  • Hyperinsulinism / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Neoplasms / drug therapy
  • PPAR alpha / agonists*

Substances

  • Glucocorticoids
  • Hypolipidemic Agents
  • PPAR alpha
  • Fenofibrate